Chemoinformaics analysis of 3,4,4-Trimethylheptadec-2-EN-2-OL
Molecular Weight | 410.683 | nRot | 23 |
Heavy Atom Molecular Weight | 360.283 | nRig | 6 |
Exact Molecular Weight | 410.376 | nRing | 0 |
Solubility: LogS | -1.707 | nHRing | 0 |
Solubility: LogP | 2.253 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 79 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 79.1656 |
nHD | 0 | BPOL | 53.6324 |
QED | 0.688 |
Synth | 2.975 |
Natural Product Likeliness | -0.599 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.308 |
MDCK | 0.0000337 |
BBB | 0.941 |
PPB | 0.551976 |
VDSS | 1.291 |
FU | 0.343799 |
CYP1A2-inh | 0.634 |
CYP1A2-sub | 0.869 |
CYP2c19-inh | 0.201 |
CYP2c19-sub | 0.91 |
CYP2c9-inh | 0.058 |
CYP2c9-sub | 0.711 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.689 |
CYP3a4-inh | 0.068 |
CYP3a4-sub | 0.491 |
CL | 6.606 |
T12 | 0.487 |
hERG | 0.016 |
Ames | 0.109 |
ROA | 0.711 |
SkinSen | 0.709 |
Carcinogencity | 0.486 |
EI | 0.862 |
Respiratory | 0.947 |
NR-Aromatase | 0.062 |
Antiviral | No |
Prediction | 0.562727 |